In addition to the increased expression of the PD-1/PD-L1 inhibitory receptors, an increase in CD4+ CD25+ FOXP3+ Tregs is observed in CLL, particularly in previously untreated advanced-stage CLL (89). This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.